JPRN-UMIN000018786已完成未知
Research on HER2 expression in metastatic colorectal cancer - HER2 expression MRC (JACCRO VV-15)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients who received neoadjuvant chemotherapy . (2) Patients who are regarded as inadequate for study enrollment by investigators.
研究者
相似试验
已完成
不适用
HER2 screening study for metastatic colorectal cancer (additional studies of GI-SCREEN 2013-01-CRC)Colorectal cancerJPRN-UMIN000030064ational Cancer Center Hospital East147
终止
1 期
Gene Therapy Using Anti-Her-2 Cells to Treat Metastatic CancerMetastatic CancerNCT00924287National Cancer Institute (NCI)1
尚未招募
不适用
HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of ChinaEndometrial CancerHER2 ExpressionOvarian CancerCervical CancerNCT06238284Chongqing University Cancer Hospital300
尚未招募
Unknown
To study the expression of HER2 immunohistochemistry in gastric cancerCTRI/2024/07/070266G B Pant institute of post graduate medical education and research
招募中
1 期
Study of Biological Effect in Tumor Samples from Clinical Trial Patients Treated with Ds8201Patients diagnosed with advanced or metastatic cancer treated with Trastuzumab Deruxtecan in the context of a clinical trial/expanded access/ compassionate use or standard treatment, irrespective of histologic type.CTIS2023-508830-33-00Solti Group180